Policy & Regulation: Page 27
-
PharmaVoice Team/PharmaVoice
UpFront
An international connection Internet and Physicians in Latin America As in the rest of the world, healthcare professionals from across Latin America use the Internet to be informed, and surprisingly, a majority use their free time to do so. A recent survey by Medimix International shows that most...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
On behalf of the PharmaLinx LLC family, I would like to thank all of those who contributed to the success of the 7th annual charity golf event. Seven years ago, believe it or not, we — Lisa Banket, Marah Walsh, and myself — not only founded the company and began publishing PharmaVOICE but establi...
By Taren Grom • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineRare diseases
As drug developers find promise in the rare diseases, deals and treatments are on the rise
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Managed Markets: Workers' Comp Pharmacy Costs Rising
By Denise Myshko Total spend for drugs in the workers’ compensation arena is expected to be $5.5 billion in 2007 and represents 15% of total medical costs associated with workers’ compensation. This is the fastest growing component of the system’s medical expense. The use of generic drugs is sign...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Lipitor Perceived as Market Leader Among Statin Brands When it comes to statins, the most frequently discussed issue in the blogosphere and general online world is the negative side effects. This is one of the findings in a recent report fielded ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Online update SURF’s UP According to Manhattan Research’s latest study, physician site traffic is spread among product sites of new and early-launch stage treatments, those with clinical news coverage, and, consistent with years past, products with a significant consumer advertising component. “W...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents September 2007 On the Cover Success Beyond the Silos Innovative pharmaceutical companies are redefining the communications process by tearing down the walls between the different factions: agencies, sales, marketing, and public relations. FEATURES Postmarketing Safety in the Spo...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
PharmaLinx Launches Industry Web Portal Professionals who operate in the pharmaceutical, biotechnology, and medical-device sectors, as well as those who provide services and tools to the industry, now have a single source to find targeted information related to their fields. The new portal, Acces...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DIA 2007 -- Annual Conference
DIA Addresses extreme topics The 43rd Annual Meeting of the Drug Information Association DIA 2007 — Annual Conference The Drug Information Association’s 43rd annual meeting featured 450 sessions and more than 1,000 speakers. Industry Thought Leaders Raise their VOICE at DIA Podcasts BBK Worldwide...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
7 Rules for New War Games
Stan Bernard of Bernard Associates says practicing competitive simulations is a better approach than war games because simulations address more of the challenges that companies face. Traditionally, businesses have engaged in war games, in which marketing groups or brand teams compete by dividing ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
New Directions for Clinical Directors
By Denise Myshko As drug development continues to become global and more complex, the clinical director’s role is changing as well. The function of the clinical director has broadened from a purely medical and scientific advisory role to being the clinical leader responsible for the design and de...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Nanotech Comes of Age
By Kim Ribbink The once futuristic science of nanotechnology has come of age and branched into a broad spectrum of applications. Among these is nanomedicine: medicinal intervention at the molecular level for curing disease, repairing damaged tissue, and monitoring biological systems. The National...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Section 199 Deduction for Qualified Production Activity Income
In October of 2004, the U.S. Congress and President Bush signed into law the American Jobs Creation Act of 2004. The Act is the first major corporate tax act in over a decade. A key provision of the Act is a new domestic manufacturing deduction designed to improve the global competitiveness of U....
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies New Healthcare Marketing and Communications Agency Created The agency helps clients identify situations and places where behavior can be influenced. Identifying a need to provide clients with a way to compete more effectively in today’s dyn...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies CIS Launches Pharma Compliance Exchange Website Compliance Implementation Services (CIS) recently released the Pharma Compliance Exchange (PCX), a new subscription-based source for government guidance documentation. For the first ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharma POOL Warwick S. Bedwell Roche Appoints VP and Global Head of Business Development, Pharma Partnering Warwick S. Bedwell has been appointed VP and global head of Roche Pharmaceutical’s Business Development — Pharma Partnering business. Roche, Nutley, N.J., is part of the Roche Group, a rese...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
May 2007 Table of Contents On the Cover Pharma’s Commitment to Public Health A natural extension of the industry’s mission of providing safe, lifesaving medicines is participation and sponsorship of myriad public-health initiatives around the world. Features Nanotech Comes of Age With products al...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
If you are feeling downtrodden by the continuing barrage of negative news about our industry, then this issue is the cure for what ails you. This issue showcases dozens of individuals who exemplify the best of the best in terms of their commitment, passion, and conviction to improving the health ...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Consumer-Driven Healthcare Retail Primary Care One in 10 retail clinic users is replacing his or her primary-care physician with a retail clinic for the treatment of common ailments, according to a recent study by Market Strategies Inc. The study indicates substantial interest by consumers to rec...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Connecting the Dots: The Big Picture in Connected Health While the adoption of electronic medical records (EMR) is enormously important — and a robust connected health vision depends on EMR — it is only one aspect of connected health as it exists today and as we envision it for tomorrow. — Joseph...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Letter from the Editor The Forum Biotech: The States of the Industry — To harness talent and leverage the niche characteristics to grow business, the biosciences require the specific capabilities certain regions have to offer. In this special Forum, Governors from five biotech-centered states rep...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Managed Markets: Hospitals
By Denise Myshko An Opportunity and a Challenge Placement on hospital formularies has become more competitive. Pharmaceutical companies that can demonstrate that their products positively impact the total cost of patient care will have the advantage. While small, the hospital market offers a uniq...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
UpFront
Drug Sales U.S. Prescription Update Sales Jumped 8.3% to $274.9 Billion IMS Health reports that U.S. prescription drug sales grew 8.3% to $274.9 billion in 2006, the third straight year of growth. The increase was fueled by the Medicare Part D prescription benefit, the increased use of generics w...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
etrials Unveils New Version of EDC Solution etrials Worldwide has unveiled EDC 2.0 solution. Combining more than 10 years of market validation and customer deployments, the newest solution builds upon existing Web-based software as a service (SaaS) solution for collecting, managing, and analyzing...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
Making Personalized Medicine Understandable Education is Key As William D. Young, CEO of Monogram Bioscience, states in The Age of Personalized Medicine, (PharmaVOICE February 2007), honestly and clearly addressing the concerns of the stakeholders (drug makers, insurance companies, doctors, and p...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
DNA-Based Diagnostics: Testing for Personalized Medicine
By Cynthia Borda Theranostic testing There will come a time when genetic testing will be as common in the physician’s office as a blood pressure reading or the use of an MRI. The pharmaceutical industry is making headway in the personalized medicine arena, and diagnostic companies are actively de...
By Cynthia Borda • Jan. 2, 2008
Previous
